Agenus Aktie

Watchlist WKN A403RK ISIN US00847G8042

Was macht Agenus?

Unternehmensprofil
Unternehmensprofil

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Chart der Agenus Aktie

Charttool öffnen